Search results
Results from the WOW.Com Content Network
It is published by Wiley and was established in 1980. [1] The editor-in-chief is Amanda E. Hargrove (Duke University). [2] The journal publishes critical reviews of topics include pathophysiology, genomics and proteomics, and clinical characteristics of important drugs.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy is a monthly peer-reviewed medical journal covering human pharmacology and pharmacotherapy, published by Wiley-Blackwell on behalf of the American College of Clinical Pharmacy, of which it is an official journal.
The Journal of Diabetes is a monthly peer-reviewed medical journal that covers research, therapeutics, and education in the field of diabetes mellitus. It is published by Wiley and is an official journal of the Chinese Society of Endocrinology and endorsed by the Chinese Endocrinologist Association .
Clinical and Translational Science is a bimonthly peer-reviewed open-access medical journal covering translational medicine. It is published by Wiley-Blackwell and is an official journal of the American Society for Clinical Pharmacology and Therapeutics. The journal was established in 2008 and the editor-in-chief is John A. Wagner (Cygnal ...
Pharmacoepidemiology and Drug Safety is a peer-reviewed scientific journal covering aspects of pharmacoepidemiology. It was established in 1992 and is published by Wiley on behalf of the International Society for Pharmacoepidemiology. The editor-in-chief is Brian L. Strom at Rutgers University. [1]
According to the Journal Citation Reports, the journal has a 2022 impact factor of 3.9. [2] It is thus ranked #11 out of 38 journals within the category of Substance Abuse. However, according to another metric, the TQCC (top quartile citation count), Journal of Substance Use and Addiction Treatment is ranked #1 in that category as of early 2024 ...
According to the Journal Citation Reports, the journal had an impact factor of 3.8 in 2022, ranking it 13th out of 38 journals in the category "Substance Abuse". [1] The journal was established in 1982 as Australian Alcohol – Drug Review, and changed its name to Australian Drug and Alcohol Review in 1986. In 1990 it obtained its current name.
According to the Journal Citation Reports, the journal has a 2022 impact factor of 3.4 and a 5-year impact factor of 3.8, ranking it 125th out of 278 journals in the category Pharmacology & Pharmacy. [1] It is in the first quartile of journals in the category "Medicine – Pharmacology (medical)" (51/255).